Cited by 22Circadian rhythm and melatoninTreatment of Major DepressionLight effects on plants

Are short (blue) wavelengths necessary for light treatment of seasonal affective disorder?

Open access
Anderson, J. L., St Hilaire, M. A., Auger, R. R., Glod, C. A., Crow, S. J., Rivera, A. N., Fuentes Salgado, S. M., Pullen, S. J. +3 more·2016·Chronobiology International

Abstract

Despite widely published speculation regarding a potential potency advantage of short-wavelength (blue-appearing) light for Seasonal Affective Disorder (SAD) treatment, there have been few systematic studies. Those comparing short-wavelength to broad-wavelength (white) light under actual clinical conditions suggest equivalent effectiveness. This multicenter, parallel-group design trial was undertaken to compare the effects of light therapy on SAD using blue (~465 nm) versus blue-free (595-612 nm) LED lights. Fifty-six medication-free subjects aged 21-64 years who met DSM-IV-TR criteria for recurrent major depression with winter-type seasonal pattern were enrolled in this blinded study at five participating centers between January and March 2012. Thirty-five subjects met the criteria for randomization to 30 min of either blue (~465 nm) or blue-free (595-612 nm) daily morning light therapy. Twenty-nine subjects completed the study; three subjects withdrew due to treatment-related adverse events, including migraines, and three withdrew for non-study-related reasons. The primary effectiveness variable was depression score (SIGH-ADS) after six weeks of daily light treatment. Secondary effectiveness variables included quality-of-life (QoL) and suicidality ratings. Using an intent-to-treat analysis, mean depression scores were different at baseline for the blue group (29 ± 5 versus 26 ± 5, p = 0.05 blue versus blue-free, respectively), and the initial score was used as a covariate. Baseline scores were not significantly different between treatment groups among those who completed the study, and no significant differences in depression scores were observed after 6 weeks (mean ± SD scores at 6 weeks: 5.6 ± 6.1 versus 4.5 ± 5.3, p = 0.74, blue versus blue-free, respectively). In addition, the proportion of subjects who met remission criteria, defined as a depression score ≤8, was not significantly different between the two groups (p = 0.41); among the 29 subjects who completed the study, 76% of subjects experienced remission by the end of the trial, which coincided with the beginning of spring. The QoL and suicidality ratings were also significantly improved from pre- to post-treatment, with no significant difference between treatments. No subject experienced worsening or non-improved symptoms over the 6-week trial. The main finding of this study is that subjects treated with blue light did not improve more than subjects treated with blue-free light; both showed substantial improvement on multiple measures. Failure to find differences may have resulted from methodological constraints, including a small sample size. Recruitment began mid-winter during an unusually mild season, and the trial was terminated earlier than planned by the study sponsor due to a failure to detect a difference. However, if confirmed in a larger randomized sample, these results suggest that blue wavelengths are not necessary for successful SAD treatment.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1080/07420528.2016.1207660

Cites

51 of 51 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Fourteen articles reported effects of various visible light interventions on SIGH-SAD of patients with SAD.

    “Fourteen articles[25–36,38,39] reported the effects of various visible light interventions on SIGH-SAD of patients with SAD.”

    From Effectiveness of visible light for seasonal affective disorder: A systematic review and network meta-analysis (2025) · cites this paper as [26]

    The Methods (Study Procedures) and Results (SIGH-ADS) show that this article tested visible-light treatments in patients with SAD and reported depression-rating outcomes. It identifies the measure as SIGH-ADS, however, not SIGH-SAD; our copy does not establish that the two names refer to the same measure. The count of fourteen articles is a statement about the citing paper’s group of references, not a finding this individual source could establish. (LLM, conf=0.82)

    Experimental — accuracy not yet measured
  • Eleven included studies accomplished double-blinding for both patients and raters, avoiding performance bias and detection bias.

    “Eleven studies accomplished the double-blind procedure for both patients and raters, effectively avoiding performance bias and detection bias.[23,25–27,29,32,35,36,38–40]”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 4

  1. Beck AT 1991 Beck Scale for Suicide Ideation San Antonio, TX Psych Corp. Pearson Education, Inc
  2. First MB Spitzer RL Gibbon M Williams JBW 2002 Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition (SCID-I/P) New York Biometrics Research, New York State Psychiatric Institute
  3. Kronauer RE Forger DB Jewett ME 2000 Errata Quantifying human circadian pacemaker response to brief, extended, and repeated light stimuli over the photopic range JBiol Rhythms 15 184 186 10643747
  4. Terman JS Terman M Schlager D Rafferty B Rosofsky M Link MJ Gallin PF Quitkin FM 1990b Identification, assessment, and treatment of seasonality in mood disorders Psychopharmacology Bulletin 26 2371371

Cited by

Sorted by citations

Authors
Anderson, J. L., St Hilaire, M. A., Auger, R. R., Glod, C. A., Crow, S. J., Rivera, A. N., Fuentes Salgado, S. M., Pullen, S. J., Kaufman, T. K., Selby, A. J., & Wolfe, D. J.
Affiliations
  • Brigham and Women's Hospital (US)
  • Harvard Medical School and Brigham & Women’s Hospital, Boston, MA, USA
  • Mayo Clinic (US)
  • Harvard University (US)
  • University of Minnesota (US)
  • Clinical Trial and Consulting (US)
  • Universidad del Desarrollo, Santiago, Chile
  • St. Luke’s Boise Medical Center (US)
  • St. Clare Hospital in Lakewood (US)
Corresponding author
Anderson, J. L.
Venue
Chronobiology International
Published
2016-08-05
Volume
33
Issue
9
Pages
1267-1279
ISSN
  • 0742-0528 (ISSN-L)
  • 1525-6073
OpenAlex
W2485144545
Cited by
22
References
51
Citations by year
2025: 1 · 2024: 4 · 2023: 2 · 2022: 5 · 2021: 2 · 2020: 2 · 2018: 2 · 2017: 2 · 2016: 1
FWCI
1.06
Type
journal article
Language
en
Open access
Locations
  • Chronobiology International (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Center for Research Resources (NIH 1 UL1 RR025758)
  • National Heart, Lung, and Blood Institute (T32 HL079010)
  • Philips Healthcare Solutions (no specific number assigned)
Topics
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
  • Life Sciences › Agricultural and Biological Sciences › Plant Science › Light effects on plants
Keywords
seasonal affective disorder, phototherapy, blue light, short-wavelength light, white light, LED light, major depressive disorder, depression remission, quality of life, suicidality, treatment efficacy comparison, medication-free treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review